novo nordisk semaglutide mash Wegovy® (semaglutide injection) Receives Conditional Marketing Authorization from Health Canada as the First and Only Treatment for Adults with Non-Cirrhotic MASH, a Serious Liver Disease Novo Nordisk GLP-1 Drug Meets

Retatrutide is the newest entrant, a triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously

Always consult with your doctor or personal dietitian before making changes to your diet

Anecdotally, we can see that the rebound hunger is stronger when you stop suddenly versus tapering, Anekwe says

Do I need cortisol monitoring whilst taking Mounjaro

When I went on the low weekly maintenance dose (blue arrow), I only experienced mild nausea at 0.375mg/week and did not experience any side effects at lower doses

Retatrutide cannot be legally prescribed or dispensed outside of authorized clinical trials, says Dr